New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals

Gut

Volumn 65, Issue 10, 2016, Pages 1690-1701

  Qi, Jingjing ^a   Yu, Yong ^a   Öztürk, Özlem Akilli ^a   Holland, Jane D ^a   Besser, Daniel ^a   Fritzmann, Johannes ^b   Wulf Goldenberg, Annika ^c   Eckert, Klaus ^c   Fichtner, Iduna ^c   Birchmeier, Walter ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c Experimental Pharmacology and Oncology EPO GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; TCF4 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BOP1 PROTEIN, MOUSE; CKS2 PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE 1; NFIL3 PROTEIN, MOUSE; NUCLEAR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOP1 GENE; CELL MIGRATION; CELL MOTILITY; CKS2 GENE; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL METASTASIS; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; MALE; MOUSE; NFIL3 GENE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; COLORECTAL TUMOR; DISEASE MODEL; EXPERIMENTAL LIVER NEOPLASM; GENETICS; LIVER TUMOR; METASTASIS; SECONDARY; TUMOR CELL CULTURE; WNT SIGNALING;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CDC28 PROTEIN KINASE, S CEREVISIAE; CELL MOVEMENT; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; NUCLEAR PROTEINS; TUMOR CELLS, CULTURED; WNT SIGNALING PATHWAY;

EID: 84937604669     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-307900     Document Type: Article

References (41)

1. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000;103:311-20.
2. Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2010;2:a002915.
3. Rustgi AK. The genetics of hereditary colon cancer. Genes Dev 2007;21:2525-38.
4. Stein U, Arlt F, Walther W, et al. The metastasis-Associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology 2006;131:1486-500.
5. Fritzmann J, Morkel M, Besser D, et al. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 2009;137:165-75.
6. Wu ZQ, Li XY, Hu CY, et al. Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci U S A 2012;109:16654-9.
7. Francis JC, Thomsen MK, Taketo MM, et al. beta-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma. PLoS Genet 2013;9:e1003180.
8. Tan M, Gong H, Zeng Y, et al. Downregulation of Homeodomain-Interacting Protein Kinase-2 Contributes to Bladder Cancer Metastasis by Regulating Wnt Signaling. J Cell Biochem 2014;115:1762-7.
9. Holland JD, Gyorffy B, Vogel R, et al. Combined Wnt/beta-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome. Cell Rep 2013;5:1214-27.
10. Christofori G. New signals from the invasive front. Nature 2006;441:444-50.
11. Sleeman J, Steeg PS. Cancer metastasis as a therapeutic target. Eur J Cancer 2010;46:1177-80.
12. Scheel C, Weinberg RA. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 2012;22:396-403.
13. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-42.
14. Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med 2014;7:1-11.
15. Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol 2014;16:488-94.
16. Sanz-Moreno V, Marshall CJ. The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr Opin Cell Biol 2010;22:690-6.
17. Ridley AJ. Life at the leading edge. Cell 2011;145:1012-22.
18. Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 2014;15:1243-53.
19. Network TCGA. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7.
20. Funamoto S, Meili R, Lee S, et al. Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 2002;109:611-23.
21. Servant G, Weiner OD, Herzmark P, et al. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 2000;287:1037-40.
22. Seo M, Lee S, Kim JH, et al. RNAi-based functional selection identifies novel cell migration determinants dependent on PI3K and AKT pathways. Nat Commun 2014;5:5217.
23. Huang C, Rajfur Z, Borchers C, et al. JNK phosphorylates paxillin and regulates cell migration. Nature 2003;424:219-23.
24. Chang L, Jones Y, Ellisman MH, et al. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-Associated proteins. Dev Cell 2003;4:521-33.
25. Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration. J Cell Sci 2004;117(Pt 20):4619-28.
26. Kobayashi M, Nishita M, Mishima T, et al. MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J 2006;25:713-26.
27. Zhou H, Huang S. Role of mTOR signaling in tumor cell motility, invasion and metastasis. Curr Protein Pept Sci 2011;12:30-42.
28. Liu L, Chen L, Chung J, et al. Rapamycin inhibits F-Actin reorganization and phosphorylation of focal adhesion proteins. Oncogene 2008;27:4998-5010.
29. Ilyas M, Tomlinson IP, Rowan A, et al. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 1997;94:10330-4.
30. Ahmed D, Eide PW, Eilertsen IA, et al. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2013;2:e71.
31. Lustig B, Jerchow B, Sachs M, et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 2002;22:1184-93.
32. Wingender E, Chen X, Hehl R, et al. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 2000;28:316-9.
33. Molenaar M, van de Wetering M, Oosterwegel M, et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996;86:391-9.
34. Stein U, Walther W, Arlt F, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009;15:59-67.
35. Bresalier RS, Raper SE, Hujanen ES, et al. A new animal model for human colon cancer metastasis. Int J Cancer 1987;39:625-30.
36. Gavert N, Sheffer M, Raveh S, et al. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res 2007;67:7703-12.
37. Gagos S, Hopwood VL, Iliopoulos D, et al. Chromosomal markers associated with metastasis in two colon cancer cell lines established from the same patient. Anticancer Res 1995;15:369-78.
38. Bhadriraju K, Yang M, Alom Ruiz S, et al. Activation of ROCK by RhoA is regulated by cell adhesion, shape, and cytoskeletal tension. Exp Cell Res 2007;313:3616-23.
39. Wassermann S1, Scheel SK, Hiendlmeyer E, et al. p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors. Gastroenterology 2009;136:196-205.e2. doi:10.1053/j.gastro.2008.09.019.
40. Sekiya T, Adachi S, Kohu K, et al. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. J Biol Chem 2004;279:6840-6.
41. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-73.